Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States

Background: As vaccines for the coronavirus become available, it will be important to know the rate of COVID-19 vaccine acceptability in adults with multiple sclerosis (MS), given that vaccination will be a key strategy for preventing SARS-CoV-2 infections. Using a national sample of adults with MS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ehde, Dawn M., Roberts, Michelle K., Herring, Tracy E., Alschuler, Kevin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825851/
https://www.ncbi.nlm.nih.gov/pubmed/33508570
http://dx.doi.org/10.1016/j.msard.2021.102788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825851/
https://www.ncbi.nlm.nih.gov/pubmed/33508570
http://dx.doi.org/10.1016/j.msard.2021.102788

Ejemplares similares